Microbot Medical Inc. (MBOT)
NASDAQ: MBOT · Real-Time Price · USD
2.100
-0.070 (-3.23%)
At close: Apr 28, 2026, 4:00 PM EDT
2.110
+0.010 (0.48%)
After-hours: Apr 28, 2026, 7:54 PM EDT

Company Description

Microbot Medical Inc. is a medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space.

The company offers LIBERTY, an endovascular robotic surgical system designed to maneuver guidewires and over-the-wire devices such as microcatheters within the body’s vasculature for use in cardiovascular, peripheral, endovascular, and neurovascular operations.

It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter.

The company has a collaboration agreement with Corewell Health for the development of LIBERTY endovascular robotic system; and Emory University, in connection with autonomous robotics in endovascular procedures.

Microbot Medical Inc. was founded in 2010 and is based in Hingham, Massachusetts

Microbot Medical Inc.
Microbot Medical logo
Country United States
Founded 2010
Industry Medical Instruments & Supplies
Sector Healthcare
Employees 43
CEO Harel Gadot

Contact Details

Address:
175 Derby Street, Bld. 27
Hingham, Massachusetts 02043
United States
Phone 781 875 3605
Website microbotmedical.com

Stock Details

Ticker Symbol MBOT
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000883975
CUSIP Number 59503A204
ISIN Number US59503A2042
Employer ID 94-3078125
SIC Code 3841

Key Executives

Name Position
Harel Gadot Co-Founder, President, Chief Executive Officer and Chairman
Rachel Vaknin Chief Financial Officer
Dr. Simon Sharon MBA, MSc Chief Technology Officer and GM of Microbot Israel
Dr. Juan Diaz-Cartelle Chief Medical Officer
Michal Ahuvia Director of Operations
Christina Bailey Vice President of Sales
Allison Rosefort Vice President of Marketing
Naama Moav Vice President of Human Resources
Michael Lytle Head of Sales Operations and Analytics

Latest SEC Filings

Date Type Title
Apr 22, 2026 8-K Current Report
Apr 14, 2026 8-K Current Report
Apr 13, 2026 8-K Current Report
Apr 10, 2026 424B5 Filing
Apr 10, 2026 8-K Current Report
Mar 26, 2026 10-K Annual Report
Mar 26, 2026 8-K Current Report
Mar 24, 2026 8-K Current Report
Mar 17, 2026 8-K Current Report
Mar 10, 2026 8-K Current Report